PAN-CANCER PROGNOSIS PREDICTION USING MULTIMODAL DEEP LEARNING

被引:0
|
作者
Silva, Luis A. Vale [1 ]
Rohr, Karl
机构
[1] Heidelberg Univ, Biomed Comp Vis Grp, BioQuant Ctr, Heidelberg, Germany
关键词
Multi-modality fusion; Machine learning; Molecular and cellular screening;
D O I
10.1109/isbi45749.2020.9098665
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the age of precision medicine, cancer prognosis assessment from high-dimensional multimodal data requires powerful computational methods. We present an end-to-end multimodal Deep Learning method, named MultiSurv, for automatic patient risk prediction for a large group of 33 cancer types. The method leverages histophatology microscopy slides combined with tabular clinical information and different types of high-throughput sequencing and microarray molecular data. MultiSurv has high predictive performance over all cancer types after training on different combinations of input data modalities and it can handle missing data seamlessly. MultiSurv thus has the potential to integrate the wide variety of available patient data and assist physicians with cancer patient prognosis.
引用
收藏
页码:568 / 571
页数:4
相关论文
共 50 条
  • [31] Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
    Zhao, Qinfei
    Hu, Weiquan
    Xu, Jing
    Zeng, Shaoying
    Xi, Xuxiang
    Chen, Jing
    Wu, Xiangsheng
    Hu, Suping
    Zhong, Tianyu
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [32] Long-term cancer survival prediction using multimodal deep learning
    Luís A. Vale-Silva
    Karl Rohr
    [J]. Scientific Reports, 11
  • [33] Multimodal Deep Learning for Cancer Survival Prediction: A Review
    Zhang, Ge
    Ma, Chenwei
    Yan, Chaokun
    Luo, Huimin
    Wang, Jianlin
    Liang, Wenjuan
    Luo, Junwei
    [J]. CURRENT BIOINFORMATICS, 2024,
  • [34] Long-term cancer survival prediction using multimodal deep learning
    Vale-Silva, Luis A.
    Rohr, Karl
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [35] Identification of lncRNA Signature Associated With Pan-Cancer Prognosis
    Bao, Guoqing
    Xu, Ran
    Wang, Xiuying
    Ji, Jianxiong
    Wang, Linlin
    Li, Wenjie
    Zhang, Qing
    Huang, Bin
    Chen, Anjing
    Zhang, Di
    Kong, Beihua
    Yang, Qifeng
    Yuan, Cunzhong
    Wang, Xinyu
    Wang, Jian
    Li, Xingang
    [J]. IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2021, 25 (06) : 2317 - 2328
  • [36] Accurate prediction of pan-cancer types using machine learning with minimal number of DNA methylation sites
    Ning, Wei
    Wu, Tao
    Wu, Chenxu
    Wang, Shixiang
    Tao, Ziyu
    Wang, Guangshuai
    Zhao, Xiangyu
    Diao, Kaixuan
    Wang, Jinyu
    Chen, Jing
    Chen, Fuxiang
    Liu, Xue-Song
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2023, 15 (04)
  • [37] Pan-cancer analysis and KNSTRN as a potential prognosis biomarker
    Xiao, Shanshan
    Zou, Yuqing
    Wang, Li
    Wang, Qian
    Wang, Tao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Multimodal adversarial representation learning for breast cancer prognosis prediction
    Du, Xiuquan
    Zhao, Yuefan
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 157
  • [39] Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
    Lin, Tong
    Zhang, Yingzhao
    Lin, Zhimei
    Peng, Lisheng
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [40] MI_DenseNetCAM: A Novel Pan-Cancer Classification and Prediction Method Based on Mutual Information and Deep Learning Model
    Wang, Jianlin
    Dai, Xuebing
    Luo, Huimin
    Yan, Chaokun
    Zhang, Ge
    Luo, Junwei
    [J]. FRONTIERS IN GENETICS, 2021, 12